Valuation Shandong Pharmaceutical Glass Co.Ltd
Stocks
600529
CNE000001BG9
Non-Paper Containers & Packaging
|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 18.17 CNY | +1.11% |
|
-0.16% | -8.83% |
| 09-18 | Shandong Pharmaceutical Glass Seeks Up to 3.2 Billion Yuan from Private Placement | MT |
| 08-24 | Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Shandong Pharmaceutical Glass Co.Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,119 | 18,847 | 16,989 | 17,101 | 13,226 | 12,058 | - | - |
| Change | - | -27.84% | -9.86% | 0.66% | -22.66% | -8.83% | - | - |
| Enterprise Value (EV) 1 | 25,234 | 17,500 | 15,524 | 16,036 | 12,166 | 9,124 | 8,661 | 8,168 |
| Change | - | -30.65% | -11.29% | 3.3% | -24.13% | -25% | -5.07% | -5.7% |
| P/E | 44.3x | 27.6x | 21.9x | 18.1x | 19.2x | 13.5x | 14.3x | 13.3x |
| PBR | 5.59x | 2.71x | 2.25x | 2.14x | 1.59x | 1.35x | 1.29x | 1.21x |
| PEG | - | 6.83x | 1.6x | 0.8x | -0.7x | 0.5x | -2.62x | 1.78x |
| Capitalization / Revenue | 6.74x | 4.5x | 3.41x | 3.34x | 2.96x | 2.38x | 2.35x | 2.22x |
| EV / Revenue | 6.51x | 4.18x | 3.12x | 3.13x | 2.72x | 1.8x | 1.69x | 1.51x |
| EV / EBITDA | 26.9x | 17.4x | 12.5x | 10.7x | 9.22x | 5.72x | 5.67x | 5.16x |
| EV / EBIT | 36.1x | 24.6x | 16.9x | 14.4x | 14.5x | 8.28x | 8.06x | 7.13x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.3 | 0.3 | 0.4 | 0.32 | 0.18 | 0.48 | 0.535 | 0.575 |
| Rate of return | 0.68% | 1.06% | 1.56% | 1.24% | 0.9% | 2.64% | 2.94% | 3.16% |
| EPS 2 | 0.99 | 1.03 | 1.17 | 1.42 | 1.04 | 1.343 | 1.27 | 1.365 |
| Distribution rate | 30.3% | 29.1% | 34.2% | 22.5% | 17.3% | 35.7% | 42.1% | 42.1% |
| Net sales 1 | 3,875 | 4,187 | 4,982 | 5,125 | 4,474 | 5,062 | 5,125 | 5,420 |
| EBITDA 1 | 938.9 | 1,006 | 1,241 | 1,498 | 1,319 | 1,596 | 1,528 | 1,582 |
| EBIT 1 | 698.3 | 711.1 | 916.4 | 1,113 | 838 | 1,102 | 1,074 | 1,146 |
| Net income 1 | 591.1 | 618.3 | 775.8 | 943 | 689.6 | 891.6 | 844.6 | 906.7 |
| Net Debt 1 | -885 | -1,347 | -1,465 | -1,065 | -1,060 | -2,934 | -3,396 | -3,890 |
| Reference price 2 | 43.90 | 28.40 | 25.60 | 25.77 | 19.93 | 18.17 | 18.17 | 18.17 |
| Nbr of stocks (in thousands) | 594,968 | 663,614 | 663,614 | 663,614 | 663,614 | 663,614 | - | - |
| Announcement Date | 25/04/22 | 24/04/23 | 22/04/24 | 24/04/25 | 06/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 13.53x | 1.8x | 5.72x | 2.64% | 1.8B | |
| 13.46x | 1.33x | 8.09x | 6.26% | 19.31B | |
| 17.68x | 2.85x | 8.01x | 3.48% | 17.49B | |
| 16.12x | 1.38x | 9.57x | 1.42% | 14.96B | |
| 18.03x | 1.76x | 10.73x | 2.31% | 13.01B | |
| 14.29x | 1.21x | 7.86x | 1.32% | 11.42B | |
| 18.37x | 2.19x | 10.39x | 1.52% | 11.35B | |
| 30.06x | 1.11x | 8.25x | 2.74% | 8.86B | |
| 22.67x | 2.02x | 9.74x | 1.61% | 7.69B | |
| Average | 18.25x | 1.74x | 8.71x | 2.59% | 11.76B | |
| Weighted average by Cap. | 17.77x | 1.76x | 8.92x | 2.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600529 Stock
- Valuation Shandong Pharmaceutical Glass Co.Ltd
Select your edition
All financial news and data tailored to specific country editions
